InsiderTrades.com logo

VINC Insider Trading

Insider Ownership Percentage: 15.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Vincerx Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vincerx Pharma Share Price & Price History

Current Price: $0.01
Price Change: ▼ Price Decrease of -0.0003 (-2.34%)
As of 02/24/2026 01:50 PM ET

This chart shows the closing price history over time for VINC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vincerx Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2023Alexander A. SeelenbergerInsiderBuy525$19.00$9,975.001,514View SEC Filing Icon  
8/9/2023Ahmed HamdyInsiderBuy845$19.00$16,055.004,533View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vincerx Pharma (NASDAQ:VINC)

44.02% of Vincerx Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VINC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vincerx Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/1/2025Sage Rhino Capital LLC85,170$45K0.0%-95.0%1.627%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC241,517$63K0.0%-3.7%10.782%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.674,193$0.55M0.0%-29.4%2.272%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC1,988,000$1.61M0.0%N/A6.700%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP328,533$0.27M0.0%+359.1%1.107%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC5,259$26K0.0%-87.4%0.025%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.666,995$3.38M0.0%+29.9%3.115%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC57,353$58K0.0%-44.4%0.268%Search for SEC Filing on Google Icon
10/26/2023Sage Rhino Capital LLC1,703,413$1.72M0.4%+1.0%7.967%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP354,377$0.46M0.0%-8.4%1.658%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd233,348$0.30M0.1%-19.8%1.091%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP426,472$0.55M0.0%+8.9%1.995%Search for SEC Filing on Google Icon
5/12/2023Long Focus Capital Management LLC545,352$0.57M0.1%-61.5%2.567%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd290,882$0.30M0.2%-6.4%1.369%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC101,762$0.10M0.0%-90.1%0.480%Search for SEC Filing on Google Icon
2/1/2023Sage Rhino Capital LLC1,686,937$1.72M0.5%+1.7%7.961%Search for SEC Filing on Google Icon
11/15/2022Long Focus Capital Management LLC1,061,505$1.47M0.1%+8.3%5.009%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP172,302$0.24M0.0%+72.1%0.813%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.206,224$0.28M0.0%N/A0.973%Search for SEC Filing on Google Icon
8/15/2022Clearline Capital LP452,184$0.60M0.1%+9.6%2.147%Search for SEC Filing on Google Icon
7/28/2022Sage Rhino Capital LLC1,658,199$2.19M0.8%+2.5%7.874%Search for SEC Filing on Google Icon
5/16/2022Clearline Capital LP412,657$1.65M0.2%+215.4%1.960%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.226,931$0.91M0.0%+257.7%1.078%Search for SEC Filing on Google Icon
2/15/2022Rubric Capital Management LP1,586,245$16.16M0.8%+20.9%7.533%Search for SEC Filing on Google Icon
2/15/2022Schonfeld Strategic Advisors LLC292,477$2.98M0.0%+8.0%1.389%Search for SEC Filing on Google Icon
2/15/2022Kingdon Capital Management L.L.C.385,000$3.92M0.5%+26.3%1.828%Search for SEC Filing on Google Icon
2/14/2022Clearline Capital LP130,856$1.33M0.1%N/A0.621%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC140,203$1.43M0.2%N/A0.666%Search for SEC Filing on Google Icon
2/14/2022Affinity Asset Advisors LLC1,135,365$11.57M4.2%+13.0%5.392%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp143,530$1.46M0.0%+19.2%0.682%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC8,151$83K0.0%N/A0.039%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.63,450$0.64M0.0%+12.3%0.301%Search for SEC Filing on Google Icon
1/7/2022Hollencrest Capital Management10,000$0.10M0.0%N/A0.048%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP200,000$3.01M0.0%N/A0.951%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC270,822$4.38M0.0%+24.0%1.288%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP332,917$5.38M0.0%-63.7%1.584%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC626,182$10.13M0.0%-1.6%2.979%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP22,444$0.36M0.0%-53.6%0.107%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC30,600$0.50M0.0%-55.7%0.146%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC217,798$3.52M0.0%+44.5%1.036%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.
Read More on Vincerx Pharma

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.01
High: $0.01

52 Week Range

Now: $0.01
Low: $0.00
High: $1.43

Volume

7,051 shs

Average Volume

3,769 shs

Market Capitalization

$65.43 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58